{"id":44,"date":"2022-08-04T04:22:33","date_gmt":"2022-08-04T04:22:33","guid":{"rendered":"https:\/\/leapfrogbio.wpengine.com\/?page_id=44"},"modified":"2026-01-13T07:15:29","modified_gmt":"2026-01-13T15:15:29","slug":"news","status":"publish","type":"page","link":"https:\/\/www.leapfrog.bio\/fr\/news\/","title":{"rendered":"Nouvelles"},"content":{"rendered":"<p><div class=\"fusion-bg-parallax\" data-bg-align=\"center bottom\" data-direction=\"right\" data-mute=\"false\" data-opacity=\"100\" data-velocity=\"-0.5\" data-mobile-enabled=\"false\" data-break_parents=\"0\" data-bg-image=\"https:\/\/www.leapfrog.bio\/wp-content\/uploads\/2025\/11\/leapfrog-bio_hero.jpg\" data-bg-repeat=\"false\" data-bg-color=\"rgba(0,0,0,0.41)\" ><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background fusion-parallax-right nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-position:center bottom;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:60px;--awb-padding-bottom:60px;--awb-padding-top-small:40px;--awb-padding-bottom-small:30px;--awb-background-color:rgba(0,0,0,0.41);--awb-background-image:url(&quot;https:\/\/www.leapfrog.bio\/wp-content\/uploads\/2025\/11\/leapfrog-bio_hero.jpg&quot;);--awb-background-size:cover;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1352px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><h1 class=\"white-text\">News<\/h1>\n<\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:80px;--awb-padding-bottom:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1352px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-blog-shortcode fusion-blog-shortcode-1 fusion-blog-archive fusion-blog-layout-large fusion-blog-pagination news-blog\"><div class=\"fusion-posts-container fusion-posts-container-pagination fusion-blog-rollover\" data-pages=\"1\"><article id=\"blog-1-post-617\" class=\"fusion-post-large post-617 post type-post status-publish format-standard hentry category-uncategorized\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/leapfrog-bio-appoints-alan-ashworth-ph-d-frs-to-chair-companys-scientific-advisory-board\/\">Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company\u2019s Scientific Advisory Board<\/a><\/h2><div class=\"fusion-post-content-container\"><p>-- Dr. Ashworth Brings Decades of Scientific and Clinical Experience Translating Synthetic Lethality Discoveries into Precision CancerTherapies -- South San Francisco, Calif., \u2013 Mar. 24, 2026 (Read [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/author\/leapfrogbio\/\" title=\"Articles par leapfrogbio\" rel=\"author\">leapfrogbio<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-03-24T07:56:32-07:00<\/span><span>mars 24, 2026<\/span><span class=\"fusion-inline-sep\">|<\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.leapfrog.bio\/fr\/leapfrog-bio-appoints-alan-ashworth-ph-d-frs-to-chair-companys-scientific-advisory-board\/\" aria-label=\"More on Leapfrog Bio Appoints Alan Ashworth, Ph.D., FRS, to Chair Company\u2019s Scientific Advisory Board\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-602\" class=\"fusion-post-large post-602 post type-post status-publish format-standard hentry category-uncategorized\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/new-data-underscoring-ability-of-leapfrog-bios-oncoslx-platform-to-identify-drug-retargeting-opportunities-for-treating-cancer-published-in-nature-portfolio-journal\/\">New Data Underscoring Ability of Leapfrog Bio\u2019s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal<\/a><\/h2><div class=\"fusion-post-content-container\"><p>-- Study highlights importance of cancer driver biology in translating results from lab to patients ---- Findings validate proprietary OncoSLX Platform\u2122, a pharmacogenetic approach that captures the [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/author\/leapfrogbio\/\" title=\"Articles par leapfrogbio\" rel=\"author\">leapfrogbio<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2026-01-12T10:23:19-08:00<\/span><span>janvier 12, 2026<\/span><span class=\"fusion-inline-sep\">|<\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.leapfrog.bio\/fr\/new-data-underscoring-ability-of-leapfrog-bios-oncoslx-platform-to-identify-drug-retargeting-opportunities-for-treating-cancer-published-in-nature-portfolio-journal\/\" aria-label=\"More on New Data Underscoring Ability of Leapfrog Bio\u2019s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-599\" class=\"fusion-post-large post-599 post type-post status-publish format-standard hentry category-uncategorized\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.nature.com\/articles\/s41540-025-00618-7\">Drugs work very differently from genetic perturbations: pharmacogenetic screening reveals druggable opportunities that traditional synthetic lethality screening is blind to<\/a><\/h2><div class=\"fusion-post-content-container\"><p>   <\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/author\/leapfrogbio\/\" title=\"Articles par leapfrogbio\" rel=\"author\">leapfrogbio<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2025-12-17T07:58:47-08:00<\/span><span>D\u00e9cembre 16, 2025<\/span><span class=\"fusion-inline-sep\">|<\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.nature.com\/articles\/s41540-025-00618-7\" aria-label=\"More on Drugs work very differently from genetic perturbations: pharmacogenetic screening reveals druggable opportunities that traditional synthetic lethality screening is blind to\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-283\" class=\"fusion-post-large post-283 post type-post status-publish format-standard hentry category-uncategorized\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/leapfrog-bio-presents-novel-genetic-sensitizing-mutation-linked-to-bet-inhibitors-and-clinical-development-plans-for-lead-product-candidate-at-the-aacr-special-conference-in-cancer-research\/\">Leapfrog Bio Presents Novel Genetic Sensitizing Mutation Linked to BET Inhibitors and Clinical Development Plans for Lead Product Candidate at the AACR Special Conference in Cancer Research<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Leapfrog Bio\u2019s Precision PGx Platform\u2122 discovered a clinically significant link between the EP300 gene and bromodomain and extra-terminal domain (BET) protein inhibitors Presentation describes the discovery, characterization, [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/author\/leapfrogbio\/\" title=\"Articles par leapfrogbio\" rel=\"author\">leapfrogbio<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2024-12-10T13:24:19-08:00<\/span><span>D\u00e9cembre 10, 2024<\/span><span class=\"fusion-inline-sep\">|<\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.leapfrog.bio\/fr\/leapfrog-bio-presents-novel-genetic-sensitizing-mutation-linked-to-bet-inhibitors-and-clinical-development-plans-for-lead-product-candidate-at-the-aacr-special-conference-in-cancer-research\/\" aria-label=\"More on Leapfrog Bio Presents Novel Genetic Sensitizing Mutation Linked to BET Inhibitors and Clinical Development Plans for Lead Product Candidate at the AACR Special Conference in Cancer Research\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-257\" class=\"fusion-post-large post-257 post type-post status-publish format-standard hentry category-uncategorized\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/leapfrog-bio-announces-publication-in-nature-pj-precision-oncology-validating-its-proprietary-precision-pgx-platform\/\">Leapfrog Bio Announces Publication in Nature PJ Precision Oncology Validating its Proprietary Precision PGx Platform\u2122<\/a><\/h2><div class=\"fusion-post-content-container\"><p> Proof-of-concept retrospective analyses performed on currently marketed cancer drugs demonstrate the clinical relevance of Precision PGx Platform\u2122 predictions Proprietary Precision PGx Platform\u2122 rapidly discovers novel therapeutic [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/author\/leapfrogbio\/\" title=\"Articles par leapfrogbio\" rel=\"author\">leapfrogbio<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2024-09-05T07:07:49-07:00<\/span><span>septembre 5, 2024<\/span><span class=\"fusion-inline-sep\">|<\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.leapfrog.bio\/fr\/leapfrog-bio-announces-publication-in-nature-pj-precision-oncology-validating-its-proprietary-precision-pgx-platform\/\" aria-label=\"More on Leapfrog Bio Announces Publication in Nature PJ Precision Oncology Validating its Proprietary Precision PGx Platform\u2122\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-1\" class=\"fusion-post-large post-1 post type-post status-publish format-standard hentry category-uncategorized\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.nature.com\/articles\/s41698-024-00673-z.epdf?sharing_token=4WOBk1gKsbNNEn_fKkk6KtRgN0jAjWel9jnR3ZoTv0OXhcSEN57QJuywq2aQTU_7rsjB5Kg1mRM_xXtZxP_J7FmJ3RZLrcPl6th8ZcZGshw18Uyoub1ZAoIqQsh0079ZHRpJ0-TRiNRdJYLN1IJhqym2tJ4HffZMy5QPdvk21NM%3D\">Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes<\/a><\/h2><div class=\"fusion-post-content-container\"><p>   <\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\"><span class=\"vcard\" style=\"display: none;\"><span class=\"fn\"><a href=\"https:\/\/www.leapfrog.bio\/fr\/author\/leapfrogbio\/\" title=\"Articles par leapfrogbio\" rel=\"author\">leapfrogbio<\/a><\/span><\/span><span class=\"updated\" style=\"display:none;\">2024-09-05T09:22:23-07:00<\/span><span>ao\u00fbt 8, 2024<\/span><span class=\"fusion-inline-sep\">|<\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.nature.com\/articles\/s41698-024-00673-z.epdf?sharing_token=4WOBk1gKsbNNEn_fKkk6KtRgN0jAjWel9jnR3ZoTv0OXhcSEN57QJuywq2aQTU_7rsjB5Kg1mRM_xXtZxP_J7FmJ3RZLrcPl6th8ZcZGshw18Uyoub1ZAoIqQsh0079ZHRpJ0-TRiNRdJYLN1IJhqym2tJ4HffZMy5QPdvk21NM%3D\" aria-label=\"More on Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes\">Read More<\/a><\/div><\/div><\/article>\n<\/div><\/div>\n<style>\n.fusion-blog-shortcode article .fusion-post-content > .fusion-alignleft > span {\n    letter-spacing: 1.5px;\n    font-size: 0.9rem;\n    opacity: 0.66;\n    text-transform: uppercase;\n}\n.alignleft, .fusion-alignleft {\n    display: block;\n    float: none;\n    margin-right: 15px;\n    padding-bottom: 5px;\n   \/*color: #7ae280;*\/ \n}\n\n.fusion-blog-shortcode .fusion-meta-info {\n    border-color: #ffffff80;\n}\n\n.fusion-blog-shortcode .fusion-read-more {\n    letter-spacing: 2px;\n    text-transform: uppercase;\n    opacity: 0.5 !important;\n    \n}\n\n.fusion-blog-shortcode .fusion-read-more:after {\n    display: none;\n}\n<\/style><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-44","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>News - Leapfrog Bio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.leapfrog.bio\/fr\/news\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News - Leapfrog Bio\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.leapfrog.bio\/fr\/news\/\" \/>\n<meta property=\"og:site_name\" content=\"Leapfrog Bio\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-13T15:15:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.leapfrog.bio\/news\/\",\"url\":\"https:\/\/www.leapfrog.bio\/news\/\",\"name\":\"News - Leapfrog Bio\",\"isPartOf\":{\"@id\":\"https:\/\/www.leapfrog.bio\/#website\"},\"datePublished\":\"2022-08-04T04:22:33+00:00\",\"dateModified\":\"2026-01-13T15:15:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.leapfrog.bio\/news\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.leapfrog.bio\/news\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.leapfrog.bio\/news\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.leapfrog.bio\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.leapfrog.bio\/#website\",\"url\":\"https:\/\/www.leapfrog.bio\/\",\"name\":\"Leapfrog Bio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.leapfrog.bio\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.leapfrog.bio\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.leapfrog.bio\/#organization\",\"name\":\"Leapfrog Bio\",\"url\":\"https:\/\/www.leapfrog.bio\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.leapfrog.bio\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.leapfrog.bio\/wp-content\/uploads\/2022\/09\/leapfrogbio-logo-retina1.png\",\"contentUrl\":\"https:\/\/www.leapfrog.bio\/wp-content\/uploads\/2022\/09\/leapfrogbio-logo-retina1.png\",\"width\":510,\"height\":90,\"caption\":\"Leapfrog Bio\"},\"image\":{\"@id\":\"https:\/\/www.leapfrog.bio\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News - Leapfrog Bio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.leapfrog.bio\/fr\/news\/","og_locale":"fr_CA","og_type":"article","og_title":"News - Leapfrog Bio","og_url":"https:\/\/www.leapfrog.bio\/fr\/news\/","og_site_name":"Leapfrog Bio","article_modified_time":"2026-01-13T15:15:29+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.leapfrog.bio\/news\/","url":"https:\/\/www.leapfrog.bio\/news\/","name":"News - Leapfrog Bio","isPartOf":{"@id":"https:\/\/www.leapfrog.bio\/#website"},"datePublished":"2022-08-04T04:22:33+00:00","dateModified":"2026-01-13T15:15:29+00:00","breadcrumb":{"@id":"https:\/\/www.leapfrog.bio\/news\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.leapfrog.bio\/news\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.leapfrog.bio\/news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.leapfrog.bio\/"},{"@type":"ListItem","position":2,"name":"News"}]},{"@type":"WebSite","@id":"https:\/\/www.leapfrog.bio\/#website","url":"https:\/\/www.leapfrog.bio\/","name":"Leapfrog Bio","description":"","publisher":{"@id":"https:\/\/www.leapfrog.bio\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.leapfrog.bio\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.leapfrog.bio\/#organization","name":"Leapfrog Bio","url":"https:\/\/www.leapfrog.bio\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.leapfrog.bio\/#\/schema\/logo\/image\/","url":"https:\/\/www.leapfrog.bio\/wp-content\/uploads\/2022\/09\/leapfrogbio-logo-retina1.png","contentUrl":"https:\/\/www.leapfrog.bio\/wp-content\/uploads\/2022\/09\/leapfrogbio-logo-retina1.png","width":510,"height":90,"caption":"Leapfrog Bio"},"image":{"@id":"https:\/\/www.leapfrog.bio\/#\/schema\/logo\/image\/"}}]}},"featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/pages\/44","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/comments?post=44"}],"version-history":[{"count":12,"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/pages\/44\/revisions"}],"predecessor-version":[{"id":615,"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/pages\/44\/revisions\/615"}],"wp:attachment":[{"href":"https:\/\/www.leapfrog.bio\/fr\/wp-json\/wp\/v2\/media?parent=44"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}